Matthew Downs

1.5k total citations
10 papers, 707 citations indexed

About

Matthew Downs is a scholar working on Epidemiology, Immunology and Otorhinolaryngology. According to data from OpenAlex, Matthew Downs has authored 10 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Immunology and 2 papers in Otorhinolaryngology. Recurrent topics in Matthew Downs's work include HIV Research and Treatment (2 papers), Oral health in cancer treatment (2 papers) and Head and Neck Cancer Studies (2 papers). Matthew Downs is often cited by papers focused on HIV Research and Treatment (2 papers), Oral health in cancer treatment (2 papers) and Head and Neck Cancer Studies (2 papers). Matthew Downs collaborates with scholars based in United States, Canada and France. Matthew Downs's co-authors include Kristen Hege, Elizabeth Connick, Ronald T. Mitsuyasu, Margo R. Roberts, Andreas Bakker, Steven G. Deeks, Andy Lin, Carl H. June, David T. Scadden and Peter A. Anton and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Ophthalmology.

In The Last Decade

Matthew Downs

10 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Downs United States	6	345	262	240	196	143	10	707
Kenneth Ganley United States	6	209 0.6×	397 1.5×	94 0.4×	89 0.5×	121 0.8×	7	608
Vincent Dussupt United States	15	118 0.3×	124 0.5×	87 0.4×	330 1.7×	227 1.6×	23	693
Jacqueline K. Flynn Australia	15	228 0.7×	336 1.3×	92 0.4×	166 0.8×	296 2.1×	28	945
Leigh A. O’Mara United States	10	227 0.7×	715 2.7×	63 0.3×	137 0.7×	168 1.2×	12	916
Jean-Philippe Belzile Canada	11	119 0.3×	241 0.9×	47 0.2×	270 1.4×	306 2.1×	13	703
David Bockstoce United States	7	98 0.3×	223 0.9×	111 0.5×	153 0.8×	159 1.1×	8	500
Barbara Sloan United States	13	102 0.3×	150 0.6×	244 1.0×	298 1.5×	182 1.3×	15	829
Thomas N. Kledal Denmark	15	288 0.8×	353 1.3×	53 0.2×	247 1.3×	52 0.4×	16	984
Julio Cotte United States	6	262 0.8×	275 1.0×	161 0.7×	186 0.9×	91 0.6×	13	553

Countries citing papers authored by Matthew Downs

Since Specialization

Citations

This map shows the geographic impact of Matthew Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Downs more than expected).

Fields of papers citing papers by Matthew Downs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Downs. The network helps show where Matthew Downs may publish in the future.

Co-authorship network of co-authors of Matthew Downs

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Downs. A scholar is included among the top collaborators of Matthew Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Downs. Matthew Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Laurens, Matthew B., Randy G. Mungwira, Osward M. Nyirenda, et al.. (2021). Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial. Clinical Infectious Diseases. 73(6). 1058–1065. 8 indexed citations

2.

Downs, Matthew, Joy C. MacDermid, Denise M. Connelly, & Janette McDougall. (2020). Current Experiences and Future Expectations for Physical Activity Participation: Perspectives of Young People with Physical Disabilities and Their Rehabilitation Clinicians. Developmental Neurorehabilitation. 24(2). 73–84. 5 indexed citations

3.

Anderson, Carryn M., Deborah Saunders, Neal Dunlap, et al.. (2020). Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 106(5). 1221–1222. 1 indexed citations

4.

Anderson, Carryn M., Deborah Saunders, Neal Dunlap, et al.. (2020). 2-Year Outcomes Of Phase Iib, Randomized, Double-Blind Trial Of GC4419 Versus Placebo To Reduce Severe Oral Mucositis Due To Concurrent Radiotherapy And Cisplatin For Head And Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e789–e789. 2 indexed citations

5.

Nickel, Miriam, Alessandro Simonati, David Jacoby, et al.. (2018). Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. The Lancet Child & Adolescent Health. 2(8). 582–590. 89 indexed citations

6.

Buhr, Kevin A., et al.. (2017). Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and Comprehensibility. Therapeutic Innovation & Regulatory Science. 52(4). 459–468. 12 indexed citations

7.

Salah, Afif Ben, Pierre Buffet, Gloria Morizot, et al.. (2009). WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. PLoS neglected tropical diseases. 3(5). e432–e432. 65 indexed citations

8.

Wittes, Janet & Matthew Downs. (2009). Outcome Measures to Assess Efficacy of Treatments for Age-Related Macular Degeneration. Ophthalmology. 116(10). S8–S14. 4 indexed citations

9.

Mitsuyasu, Ronald T., Peter A. Anton, Steven G. Deeks, et al.. (2000). Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects. Blood. 96(3). 785–793. 186 indexed citations

10.

Mitsuyasu, Ronald T., Peter A. Anton, Steven G. Deeks, et al.. (2000). Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects. Blood. 96(3). 785–793. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact